Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GISTs) is Effective and Safe: Results from a Prospective Single-Center Study with 108 Patients

CONCLUSION: This study shows that neoadjuvant imatinib is effective and safe for patients with large or locally advanced GIST.PMID:37814179 | DOI:10.1245/s10434-023-14346-x

Source: Ann Oncol - October 9, 2023 Category: Cancer & Oncology Authors: Stijn J C van der Burg Deborah van de Wal Evelyne Roets Neeltje Steeghs Johanna W van Sandick Martijn Kerst Frits van Coevorden Koen J Hartemink Xander A A F A Veenhof Anne Miek Koenen Nikki Ijzerman Winette T A van der Graaf Yvonne M Schrage Winan J van Source Type: research